Skip to main content

Month: April 2023

Verde Bio Holdings Announces Engagement of Investment Bank and Corporate Update

FRISCO, TX, April 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Verde Bio Holdings, Inc. (OTCQB: VBHI) (www.verdebh.com) today announced today that it has engaged a New York based investment banking firm to act as advisor, lead underwriter, and deal manager for any future public offering and simultaneous up-listing as well as highlighting and exposing VBHI to the broader based investment community. Scott Cox, VBHI CEO, declared, “We are very pleased with this opportunity and look forward to a long-term successful investment banking relationship. With VBHI currently trading at approximately 1/5 of its asset value, we believe this relationship will provide us with more exposure to the investment community as well as allowing the Company to scale and grow aggressively due to the long-term expected demand of oil and natural...

Continue reading

Magna Celebrates a Production Milestone: 500,000 Mercedes G-Class Vehicles

Magna’s Graz Production Facility Magna milestone reached: 500,000 Mercedes G-Class vehicles producedA half a million G-Class vehicles have rolled out of Graz Significant milestone in the long-term partnership with Mercedes-Benz Milestone reflects Magna´s long history as leading contract manufacturerGRAZ, Austria, April 20, 2023 (GLOBE NEWSWIRE) — The Mercedes G-Class is one of the most iconic luxury SUVs globally and has been built by Magna since 1979. The legendary off-road vehicle entered its 44th year of production in Graz, Austria and has reached the historic mark of 500,000 produced vehicles. “A half a million of this iconic vehicle is a significant milestone which underscores Magna’s competencies as a highly flexible and experienced contract manufacturing partner. Our partnership with Mercedes-Benz has been one...

Continue reading

Tornado Global Hydrovacs Reports 2022 Results Including Record Revenue, EBITDAS, Gross Profit and Net Income

Revenue Increased by 80% Compared to 2021 CALGARY, Alberta, April 20, 2023 (GLOBE NEWSWIRE) — Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) today reported its audited consolidated financial results for the quarter and year ended December 31, 2022. The audited consolidated financial statements and related management discussion and analysis are available on the Company’s issuer profile in Canada on SEDAR at www.sedar.com, the United States at www.otcmarkets.com and on the Company’s website www.tornadotrucks.com. All amounts reported in this news release are in thousands ($000’s CAD) except per share amounts. Financial and Operating Highlights (in CAD $000’s except per share data)  Three months ended December 31   Year ended December 31    2022     2021       2022     2021             Revenue $ ...

Continue reading

Sensei Biotherapeutics Announces IND Clearance by U.S. FDA Enabling Phase 1 Initiation for SNS-101, a Conditionally Active VISTA-Blocking Antibody

First patient dose in the Phase 1/2 clinical trial expected in mid-2023 BOSTON, April 20, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SNS-101, a conditionally active VISTA-blocking antibody, paving the way for the Company to conduct a Phase 1/2 clinical trial in patients with solid tumors. “Receiving IND clearance to advance our first conditionally active antibody into a Phase 1/2 clinical trial represents an important milestone for Sensei. We believe that SNS-101 has the potential to make a significant impact in the field and to improve the lives of cancer patients...

Continue reading

Watsco Reports First Quarter EPS of $2.83 on Record Sales

Entrepreneurial Culture, Industry Scale, Technology Adoption and Regulatory Changes Contribute to Strong Margins and Support Long-Term Growth MIAMI, April 20, 2023 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced its operating results for the first quarter ended March 31, 2023 and provided commentary on business trends, growth opportunities, technology innovation and its financial position. Through its entrepreneurial and technology-driven culture, Watsco has established itself as the largest participant in the highly fragmented $50+ billion North American HVAC/R distribution market. Since entering distribution in 1989, sales and operating income have grown at compounded annual growth rates (CAGRs) of 15% and 19%, respectively, reflecting strong and consistent performance across various macroeconomic and industry cycles. Over...

Continue reading

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

Acquisition Transforms the Company into a Broader Pharmaceutical Company Spanning Multiple Sectors Company Announces Corporate Name Change to Underscore Broader Focus Company to Host a Conference call Today, April 20th, at 8:30am EDT to Discuss Asset Purchase and Company Transformation CINCINNATI, April 20, 2023 (GLOBE NEWSWIRE) —  Blue Water Vaccines Inc. (“BWV” or “Blue Water” or the “Company”), today announced the signing of an Asset Purchase Agreement (the “Agreement”) with Veru Inc. (“Veru”) for the purchase of ENTADFI®, an FDA-approved treatment for benign prostatic hyperplasia (“BPH”) that counteracts negative sexual side effects seen in men on alternative BPH therapies. Under this Agreement, Blue Water will purchase ENTADFI® for a total consideration of $100 million, with $20 million upfront, paid in defined tranches...

Continue reading

Texas Capital Bancshares, Inc. Announces First Quarter 2023 Results

First quarter 2023 net income of $38.7 million and net income available to common stockholders of $34.3 million, or $0.70 per diluted share; both declining $1.0 million compared to first quarter 2022 First quarter 2023 Pre-Provision Net Revenue(1) grew $28.0 million (55%) compared to first quarter 2022 Top tier liquidity and capital ratios maintained, enabling continued execution of the strategic plan; Cash andSecurities to Total Assets of 28.0% and Tangible Common Equity to Tangible Assets(2) of 9.7% Total deposits declined 3%; continuing communicated execution of long-term deposit mix shift away from highest cost sources DALLAS, April 20, 2023 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, announced operating results for the first quarter of 2023. Net income available...

Continue reading

Correction: WithSecure Corporation’s Interim report January-March 2023

WithSecure Corporation, Interim report (correction) January-March 2023, 20 April 2023 at 12:30 EEST Correction: WithSecure Corporation’s Interim report January-March 2023 WithSecure Corporation corrects the revenue by geographical area disclosure presented in Note 2 (Segment information) of the Interim report January-March 2023 that was published on 20 April 2023 at 8:00 am EEST. Revenue by geographic area was incorrectly disclosed. Corrected table for Note 2 (Segment information, Disaggregation of revenue, By geographical area) on page 21 of the report is shown below. Corrected Interim report is attached to this release, and updated to the company website Materials | Investor Relations | WithSecure™By geographical area 1–3/2023 1–3/2022 1–12/2022Nordic countries 10,811 10,022 40,985Rest of Europe 15,820 13,812 60,383North...

Continue reading

Talenom Plc’s Business Review January-March 2023: Growth continued as strong in line with the selected strategy

Talenom Plc, Stock exchange release, 20 April 2023 at 9:00 EEST Talenom Plc’s Business Review January-March 2023: Growth continued as strong in line with the selected strategy January–March 2023 in briefNet sales EUR 31.3 million (25.2), growth 24.2% (24.1) EBITDA EUR 8.4 million (8.9), 26.7% (35.2) of net sales Operating profit (EBIT) EUR 3.5 million (4.9), 11.0% (19.3) of net sales Net profit EUR 2.1 million (3.7) Earnings per share EUR 0.05 (0.09)Key figuresGroup 1–3/2023 1–3/2022 Change, %Net sales, EUR 1,000 31,311 25,209 24.2%Net sales, increase % 24.2% 24.1%  EBITDA, EUR 1,000 8,365 8,864 -5.6%EBITDA of net sales, % 26.7% 35.2%  Operating profit (EBIT), EUR 1,000 3,458 4,861 -28.9%Operating profit (EBIT), as % of net sales 11.0% 19.3%  Return on investment (ROI), % (rolling 12 months) 11.7% 16.8%  Interest-bearing...

Continue reading

RoodMicrotec N.V. publishes 2022 annual report with audited financial statements

RoodMicrotec shows strong financial performance for the year 2022.Total income of EUR 16.5 million with an EBITDA of EUR 3.9 million Net profit of EUR 2.4 million Cash flow from operating activities of EUR 3.6 millionDeventer, April 20, 2023 – RoodMicrotec N.V., a leading independent company for semiconductors supply and quality services, today publishes the Company’s Annual Report for the financial year 2022 including the audited consolidated and company financial statements. The 2022 Annual Report is available for download on the corporate website: www.roodmicrotec.com/en/investor-relations-en/financial-publications. The total income for 2022 amounted to EUR 16.5 million, which is 14% higher than in 2021 (EUR 14.5 million) resulting in a second consecutive year with double-digit growth. Notably, this is the highest total income...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.